$JPM

BofA Securities Adjusts Price Target on JPMorgan Chase to $400 From $420

BofA Securities reduced its price target for JPMorgan Chase from $420 to $400. The bank's stock was trading at $333.37, up 0.30% on the day but down 1.20% over a month.

Original reporting
Published Oct 5, 2026, 4:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 4:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$JPM
Bearish
high confidence
Mentioned
$JPM
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$JPMBearishMed
01

Why it matters

A $20 reduction in target signals a shift in valuation assumptions, potentially prompting short sellers or profit-taking.

02

Market read

The target cut may influence JPMorgan's share price and could ripple through the broader banking sector.

03

What to watch

Potential hidden upside from upcoming earnings or regulatory developments not reflected in the target.

Relevance 7/10Novelty 7/10Timing: today

Background

BofA Securities regularly updates price targets based on its internal models and market conditions.

Company-level read

Ticker impact

$JPMBearishHigh confidence
Context

BofA Securities lowered its price target for JPMorgan Chase to $400 from $420, a new analyst forecast.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

Analyst target revisions are a direct catalyst that can move the stock, especially when the cut is sizable.

Market effects

May weigh on other large banks as analysts reassess sector valuations.

U.S. financial sector could see modest downside pressure.

Limited to banking sector; no broad macro effect.

Counterpoint

Some investors may view the cut as an overreaction and see buying opportunity.

Key entities

  • JPMorgan Chase

    U.S. multinational bank and the subject of the price‑target change.

  • BofA Securities

    Research arm of Bank of America that issued the target revision.

Related articles

$JPMHighAI 8/10

JPMorgan Chase: Barclays Reiterates Overweight Rating

Barclays reiterated its Overweight rating on JPMorgan Chase (JPM). The bank reported Q2 2026 net income of $21.2B and EPS of $7.70, with adjusted figures of $16.9B and $6.14. Barclays advises evaluating JPMorgan's recurring profitability, deposit pricing, and fee income sustainability.

$SOFIMed

Institutional Stablecoin Settlement Just Went From Zero to Four Production Rails in a Single Month

Stablecoin settlement volume grew significantly in September 2026, with $1.2B spent on stablecoin-linked cards. SoFi and Mastercard launched SoFiUSD for card settlements, migrating $25B annualized volume. Visa's stablecoin settlement reached $20B annualized, a 15x increase. Stripe expanded stablecoin card programs to 100+ countries. Solana launched a DvP standard for faster, cheaper settlements.

$JPMMed

JPMorgan Stock Is Up Just 3% This Year as Its Multiple Shrank. Here’s What Doug Petno’s Q3 Guidance Says About the Gap

JPMorgan Chase (JPM) stock is up 3.2% YTD, trading at $332.38. Analysts expect ~$24 EPS over the next 12 months, reducing its forward P/E to ~14x. BofA and UBS cut price targets to $400 and $395, respectively, both maintaining Buy ratings. JPMorgan's Q3 results are due October 13, with guidance from CEO Doug Petno suggesting mid- to high-teens growth in investment banking fees and Markets revenue.

$AAPLMed

ICE, OKX venture plans trading of tokenized US stocks via Uniswap pools

OKXICE, a joint venture between Intercontinental Exchange and OKX, plans to trade tokenized US stocks via Uniswap pools on OKX's blockchain. The SEC exemption allows trading of over 60 stocks, including Apple, Nvidia, and Tesla, against stablecoins. Trading could start in early November, pending a 30-day waiting period. OKXICE controls the pools and trading permissions. Cerebras has objected to their stock being included.